XWPharma
China - WuhanPharmaceutical
Focus: XWPharma is a 5,000+ employee pharmaceutical company headquartered in Wuhan, China, focused on small-molecule drug development with a specialization in neurology. Founded in 1999 and currently at Series B stage, the company operates as a regional player in the Chinese pharma market.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Funding Stage
SERIES B
Employees
5000+
Total Funding
$40M
Open Jobs
0
About XWPharma
AI assessmentNot HiringNo open roles listed right now. Follow XWPharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
XW10172
HealthyClinical Trials (1)
NCT04688580Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Formulations in Healthy Adult Volunteers
Phase 1Help build intelligence for XWPharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.